Therapeutic inhibition of lactate dehydrogenase and agents therefor
US11053502B1 · kind B1 · utility
2Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2020 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | Dec 18, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.